Amifostine is a cytoprotective adjuvant used in cancer chemotherapy and
radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by ...
Amifostine has been shown to specifically protect normal tissues from damage
caused by radiation and chemotherapy. An inactive prodrug, amifostine is ...
Easy to read patient leaflet for amifostine. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Medscape - Indication-specific dosing for Ethyol, (amifostine), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
The aminothiol amifostine (Ethyol) is the subject of extensive research as a
protector. Several studies have demonstrated that amifostine protects normal
Drug Metabol Drug Interact. 2000;16(4):237-79. Amifostine: mechanisms of
action underlying cytoprotection and chemoprevention. Grdina DJ(1), Kataoka Y,
Jan 10, 2011 ... Amifostine was formed by the addition of a phosphate group to the ... years, the
subcutaneous (SC) route of amifostine administration has been ...
Amifostine Base is a phosphorylated aminosulfhydryl compound with
cytoprotective activity. Amifostine is dephosphorylated by alkaline phosphatase
to an ...
Oncologist. 2007 Jun;12(6):738-47. Amifostine: the first selective-target and
broad-spectrum radioprotector. Kouvaris JR(1), Kouloulias VE, Vlahos LJ.
Amifostine pretreatment for protection against cyclophosphamide-induced and
cisplatin-induced toxicities: results of a randomized control trial in patients with ...